Cargando…

Everolimus treatment in advanced solid tumors: a personal view

Detalles Bibliográficos
Autores principales:	Pusceddu, Sara, Indini, Alice, Procopio, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2015
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137986/ https://www.ncbi.nlm.nih.gov/pubmed/28031878 http://dx.doi.org/10.4155/fso.14.1

Ejemplares similares

Extending Validity of the Bacterial Cell Cycle Model through Thymine Limitation: A Personal View
por: Zaritsky, Arieh
Publicado: (2023)

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017)

Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors
por: Indini, Alice, et al.
Publicado: (2021)

Advances in Influenza Virus Research: A Personal Perspective
por: Subbarao, Kanta
Publicado: (2018)

Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study
por: Weeber, Fleur, et al.
Publicado: (2017)

Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
por: Cen, Putao, et al.
Publicado: (2012)

Viral hemorrhagic fevers: advancing the level of treatment
por: Ippolito, Giuseppe, et al.
Publicado: (2012)

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
por: Cascone, T., et al.
Publicado: (2021)

Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
por: Kartolo, Adi, et al.
Publicado: (2021)

Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors
por: Xu, BingHe, et al.
Publicado: (2011)

Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
por: Russo, Massimo, et al.
Publicado: (2020)

Exome sequencing: the expert view
por: Biesecker, Leslie G, et al.
Publicado: (2011)

PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls
por: Franza, A., et al.
Publicado: (2021)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

Immunotherapies for Pediatric Solid Tumors: A Targeted Update
por: Gupta, Ajay, et al.
Publicado: (2021)

A View on the Role of Epigenetics in the Biology of Malaria Parasites
por: Cortés, Alfred, et al.
Publicado: (2012)

Molecular tumor profiling: translating genomic insights into clinical advances
por: Trainer, Alison H
Publicado: (2004)

Gestational diabetes mellitus—right person, right treatment, right time?
por: Lindsay, Robert S., et al.
Publicado: (2017)

Medical regulation and financial conflicts: a view from the past
por: Walsh, Kieran
Publicado: (2015)

Botulinum Neurotoxin Diversity from a Gene-Centered View
por: Benoit, Roger M.
Publicado: (2018)

Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours
por: Campone, M, et al.
Publicado: (2009)

Mitochondrial network morphology: building an integrative, geometrical view
por: Rafelski, Susanne M
Publicado: (2013)

Psoriasis, Is It a Microdamage of Our “Sixth Sense”? A Neurocentric View
por: Sonkodi, Balázs
Publicado: (2022)

Phase I Clinical and Pharmacokinetic Study of RAD001 (Everolimus) Administered Daily to Japanese Patients with Advanced Solid Tumors
por: Okamoto, Isamu, et al.
Publicado: (2010)

Advancing the evaluation of integrated knowledge translation
por: Kreindler, Sara A.
Publicado: (2018)

Emerging use of everolimus in the treatment of neuroendocrine tumors
por: Gajate, Pablo, et al.
Publicado: (2017)

Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
por: Vitali, Eleonora, et al.
Publicado: (2020)

Antihypertensive Drug and Inner Ear Perfusion: An Otologist’s Point of View
por: Pirodda, Antonio
Publicado: (2009)

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies
por: Pusceddu, Sara, et al.
Publicado: (2016)

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
por: Berton, A. M., et al.
Publicado: (2020)

The Re-Emergence of COVID-19 in 2022 Has Affected People’s Views on Vaccines
por: Wu, Yufei, et al.
Publicado: (2022)

A Personal History in Parasitic Weeds and Their Control
por: Parker, Chris
Publicado: (2021)

Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion
por: Moiseenko, Fedor, et al.
Publicado: (2017)

The Concept of Missing Incidents in Persons with Dementia
por: Rowe, Meredeth, et al.
Publicado: (2015)

The multiple personalities of Watson and Crick strands
por: Cartwright, Reed A, et al.
Publicado: (2011)

Supra-personal cognitive control and metacognition
por: Shea, Nicholas, et al.
Publicado: (2014)

Digital Health Sensing for Personalized Dermatology
por: Spinazze, Pier, et al.
Publicado: (2019)

Transforming Life: A Broad View of the Developmental Origins of Health and Disease Concept from an Ecological Justice Perspective
por: Prescott, Susan L., et al.
Publicado: (2016)

Proposal of “cyclic therapy”, a novel treatment strategy with targeted agents for advanced renal cell carcinoma
por: Nozawa, Masahiro, et al.
Publicado: (2013)

Organizing knowledge to enable personalization of medicine in cancer
por: Good, Benjamin M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qudke3u1f1psfqc8cnt679dt3b